Stephen is a Research Analyst at Vestal Point, primarily focusing on commercial stage therapeutics. Prior to Vestal Point, Stephen was an Analyst working alongside Ryan Wilder at Point72 (2015-2023) with primary coverage of commercial stage pharmaceuticals and biotechnology companies.

Before joining Point72, he was an Investment Banking Analyst/Associate at Citigroup from 2010 to 2015. Stephen graduated from Lehigh University with a B.S. in Finance.